TV, F., & G, S. (2016). Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors. Endocrine, 53(2), 373. https://doi.org/10.1007/s12020-015-0811-7
Chicago Style (17th ed.) CitationTV, Fiorentino, and Sesti G. "Lessons Learned from Cardiovascular Outcome Clinical Trials with Dipeptidyl Peptidase 4 (DPP-4) Inhibitors." Endocrine 53, no. 2 (2016): 373. https://doi.org/10.1007/s12020-015-0811-7.
MLA (9th ed.) CitationTV, Fiorentino, and Sesti G. "Lessons Learned from Cardiovascular Outcome Clinical Trials with Dipeptidyl Peptidase 4 (DPP-4) Inhibitors." Endocrine, vol. 53, no. 2, 2016, p. 373, https://doi.org/10.1007/s12020-015-0811-7.
Warning: These citations may not always be 100% accurate.